Subcutaneous Progesterone
Subcutaneous Progesterone is a pharmaceutical formulation of progesterone administered via subcutaneous injection, serving as a method of luteal phase support by delivering sustained systemic progesterone to maintain endometrial receptivity during assisted reproductive cycles.
81
Publications
3.2K
Citations
365
Authors
141
Institutions
Publications per year
2017–2026
14
Parents
81
1–5 of 81
365
3
h-index
3
h-index
2
h-index
2
h-index
2
h-index
1–5 of 365
141
University of Wisconsin–Madison
Madison, United States
3 h-index
9 publications
440 citations
IBSA Institut Biochimique (Switzerland)
Lugano, Switzerland
3 h-index
4 publications
287 citations

University of Naples Federico II
Naples, Italy
2 h-index
7 publications
375 citations

St Bartholomew's Hospital
London, United Kingdom
2 h-index
4 publications
315 citations
Skive Hospital
Skive, Denmark
2 h-index
8 publications
263 citations

Magna Graecia University
Catanzaro, Italy
2 h-index
10 publications
158 citations

University of Nottingham
Nottingham, United Kingdom
2 h-index
6 publications
159 citations

Aarhus University
Aarhus, Denmark
2 h-index
4 publications
131 citations
1–8 of 141
6 publications · 174 citations
6
h-index
6 publications · 648 citations
6
h-index
4 publications · 76 citations
4
h-index
4 publications · 127 citations
4
h-index
4 publications · 129 citations
4
h-index
1–5